Fuan Pharmaceutical (Group) Co., Ltd. (SHE:300194)

China · Delayed Price · Currency is CNY

4.090

+0.130 (3.28%)

Aug 20, 2026, 3:04 PM CST

-17.37% (1Y)

Market Cap	4.87B -16.7%
Revenue (ttm)	1.68B -18.1%
Net Income	62.86M -72.2%
EPS	0.05 -74.9%
Shares Out	1.19B
PE Ratio	82.64
Forward PE	n/a
Dividend	0.07 (1.75%)
Ex-Dividend Date	May 28, 2026

Volume	37,774,845
Open	3.970
Previous Close	3.960
Day's Range	3.970 - 4.200
52-Week Range	3.240 - 5.110
Beta	0.24
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About SHE:300194

Fuan Pharmaceutical (Group) Co., Ltd., together with its subsidiaries, research and develops, produces, and sells chemical drugs in the People's Republic of China and internationally. It offers APIs; intermediates; and FDFs, such as anti-tumor, specialty drugs, antibiotics, as well as freeze-drying preparation for injection. The company was formerly known as Chongqing Fuan Pharmaceutical (Group) Co., Ltd. and changed its name to Fuan Pharmaceutical (Group) Co., Ltd. in August 2013. The company was founded in 2004 and is headquartered in Chongqi... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2004

Employees 2,988

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300194

Full Company Profile

Financial Performance

In 2025, SHE:300194's revenue was 1.74 billion, a decrease of -27.31% compared to the previous year's 2.39 billion. Earnings were 77.00 million, a decrease of -72.49%.

Financial Statements